Client & Alumni News

Ben Franklin Alumnus OraSure Technologies Announces New Agreement with Thermo Fisher Scientific

OraSure Technologies, Inc. (NASDAQ:OSUR) has reached an agreement with Thermo Fisher Scientific to develop and supply up to 12 homogenous fully automated oral fluid drugs of abuse assays to be used with a new Intercept® oral fluid specimen collection device. OraSure’s current Intercept® Oral Fluid Drug Testing System was the first FDA-cleared in-vitro diagnostic laboratory-based oral fluid drug testing system, and is the only one that is FDA-cleared for detection of nine commonly abused drugs. Read more.